Loading...

Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma

In the present study, we evaluated the efficacy and safety of rituximab in combination with standard doxorubicin, bleomycin, vinblastine, and dacarbazine (RABVD) in patients with classical Hodgkin lymphoma (cHL). In this phase 2 study, patients with chemotherapy-naive, advanced-stage cHL were treate...

Full description

Saved in:
Bibliographic Details
Main Authors: Younes, Anas, Oki, Yasuhiro, McLaughlin, Peter, Copeland, Amanda R., Goy, Andre, Pro, Barbara, Feng, Lei, Yuan, Ying, Chuang, Hubert H., Macapinlac, Homer A., Hagemeister, Fredrick, Romaguera, Jorge, Samaniego, Felipe, Fanale, Michelle A., Dabaja, Bouthaina Shbib, Rodriguez, Maria A., Dang, Nam, Kwak, Larry W., Neelapu, Sattva S., Fayad, Luis E.
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2012
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3359733/
https://ncbi.nlm.nih.gov/pubmed/22371887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-01-405456
Tags: Add Tag
No Tags, Be the first to tag this record!